Clinical Trial Update: A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence [Phase 1, Phase 2]

View source ↗

Summary

A double-blinded Phase 1/2 trial evaluating an alpha-adrenergic agonist ointment for idiopathic fecal incontinence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence
• Idiopathic Fecal Incontinence

Drugs mentioned

• Alpha agonist ointment (alpha-adrenergic agonist ointment)

Snippet

Sponsor: RDD Pharma Ltd | Conditions: Idiopathic Fecal Incontinence | Phase 1, Phase 2 | Status: WITHDRAWN